Article ; Online: Macular perfusion changes in people administered two types of COVID-19 vaccines: optical coherence tomography angiography study.
Arquivos brasileiros de oftalmologia
2024 Volume 87, Issue 3, Page(s) e20230051
Abstract: Purpose: To evaluate macular chorioretinal flow changes on optical coherence tomography angiography, in participants who received inactivated and messenger RNA (mRNA) vaccines to prevent Coronavirus disease 2019 (COVID-19).: Methods: In this ... ...
| Abstract | Purpose: To evaluate macular chorioretinal flow changes on optical coherence tomography angiography, in participants who received inactivated and messenger RNA (mRNA) vaccines to prevent Coronavirus disease 2019 (COVID-19). Methods: In this prospective cohort study, healthy participants who received two doses of an inactivated COVID-19 vaccine (CoronaVac) and then one dose of an mRNA vaccine (BNT162b2) were examined before and after each vaccination. Ophthalmologic examination and imaging with optical coherence tomography angiography were performed during each visit. We evaluated vascular densities in the superficial and deep capillary plexuses in foveal, parafoveal, and perifoveal areas; the foveal avascular zone; and choriocapillaris flows (in 1- and 6-mm-diameter areas). Results: One eye in each of the 24 participants was assessed. Superficial capillary plexus vascular densities in the parafoveal area were significantly lower after the second dose of the CoronaVac vaccine than after the first dose. In the deep capillary plexus, vascular attenuation was observed only in the parafoveal region after the first CoronaVac dose. However, in all regions, the deep capillary plexus vascular densities and subfoveal choriocapillaris flow were significantly decreased after the second CoronaVac dose. After the BNT162b2 dose, the superficial capillary plexus vascular densities, the deep capillary plexus vascular densities, and subfoveal choriocapillaris flow of most regions were significantly lower than those before vaccinations. Conclusion: Vascular attenuation, observed particularly after the second dose of the CoronaVac vaccine, may explain the pathogenesis of postvaccine ocular ischemic disorders reported in the literature. However, these disorders are extremely rare, and the incidence of thrombotic events caused by COVID-19 itself is higher. |
|---|---|
| MeSH term(s) | Humans ; Retinal Vessels/diagnostic imaging ; Retinal Vessels/pathology ; Fluorescein Angiography/methods ; COVID-19 Vaccines ; BNT162 Vaccine ; Tomography, Optical Coherence/methods ; Prospective Studies ; COVID-19/prevention & control ; Perfusion |
| Chemical Substances | COVID-19 Vaccines ; BNT162 Vaccine |
| Language | English |
| Publishing date | 2024-03-22 |
| Publishing country | Brazil |
| Document type | Journal Article |
| ZDB-ID | 603915-7 |
| ISSN | 1678-2925 ; 0004-2749 |
| ISSN (online) | 1678-2925 |
| ISSN | 0004-2749 |
| DOI | 10.5935/0004-2749.2023-0051 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.B 503: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
| Zs.MO 317: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.